Nav: Home

Heart cells respond to heart attack and increase the chance of survival

September 18, 2019

The heart of humans and mice does not completely recover after a heart attack. It now turns out that cells close to area of the heart attack respond to the damage resulting from the heart attack, and that this response is important for survival. This was discovered by researchers from the groups of Jeroen Bakkers (Hubrecht Institute) and Vincent Christoffels (Amsterdam UMC). Additional research on these cells, and on similar cells in animals in which the heart does completely recover after a heart attack, may lead to new treatments for patients with heart damage in the future. The results of this research were published in the scientific journal Circulation.

Heart attack

Cardiovascular diseases remain the main cause of death in the Western world. After a heart attack, scar tissue replaces the lost heart muscle. Because of this, the damage to the heart is permanent and patients are considered to have chronic heart disease. In some animals however, such as the zebrafish, the heart does fully recover after a heart attack. Researchers have already discovered previously that this recovery happens in the healthy heart tissue directly adjacent to the damaged area of the heart. This area is called the border zone. Studying this border zone in different species can teach us more about the response of the heart to a heart attack, so that we may eventually induce this response in humans to recover the lost heart muscle after a heart attack.

Important gene

Researchers have now discovered that the mouse heart, which is permanently damaged after a heart attack just like the human heart, also develops a border zone. "In the border zone cells, the gene program that is normally active in the heart muscle cells was replaced by a gene program that helps the cells deal with the heart damage," says Karel van Duivenboden, researcher in the group of Vincent Christoffels (Amsterdam UMC). The researchers discovered that this program is incredibly important for surviving a heart attack. When they turned off one of the genes in this program, called NPPB, in mice with a heart attack, the chance of survival became much smaller.

Humans

By studying heart tissue of patients that had a heart attack, the researchers also identified a border zone in humans. This border zone turns out to respond in a similar way to a heart attack as the border zone in mice. However, the human border zone turned out to be located in a different area than doctors had thought until now.

Dream for the future

"Now that we know that humans also develop a border zone after a heart attack, we can start to investigate why the heart of humans and mice does not recover after a heart attack, while the hearts of some other animals do," explains Dennis de Bakker, researcher in the group of Jeroen Bakkers (Hubrecht Institute). We may eventually be able to activate cells in the border zone to start growing back the lost heart tissue, in order to restore the heart after a heart attack. "For now, however, this remains a dream for the future," according to De Bakker.
-end-
Publication

Conserved NPPB+ border zone switches from MEF2 to AP-1 driven gene program. Karel van Duijvenboden*, Dennis E.M. de Bakker*, Joyce C.K. Man*, Rob Janssen*, Marie Günthel*, Matthew C. Hill, Ingeborg B. Hooijkaas, Ingeborg van der Made, Petra H. van der Kraak, Aryan Vink, Esther E. Creemers, James F. Martin, Phil Barnett, Jeroen Bakkers#, Vincent M. Christoffels#. Circulation 2019.

* equal contribution, # shared last author

Jeroen Bakkers is group leader at the Hubrecht Institute and professor of Molecular Cardiogenetics at the UMC Utrecht.

Vincent Christoffels is group leader and professor of Developmental Biology at the Amsterdam UMC, University of Amsterdam.

About the Hubrecht Institute

The Hubrecht Institute is a research institute focused on developmental and stem cell biology. It encompasses 22 research groups that perform fundamental and multidisciplinary research, both in healthy systems and disease models. The Hubrecht Institute is a research institute of the Royal Netherlands Academy of Arts and Sciences (KNAW), situated on Utrecht Science Park. Since 2008, the institute is affiliated with the UMC Utrecht, advancing the translation of research to the clinic. The Hubrecht Institute has a partnership with the European Molecular Biology Laboratory (EMBL). For more information, visit http://www.hubrecht.eu.

Hubrecht Institute

Related Heart Attack Articles:

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.
New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.
Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.
A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.
Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.
Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.
Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.
How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.
Heart attack patients taken directly to heart centers have better long-term survival
Heart attack patients taken directly to heart centers for lifesaving treatment have better long-term survival than those transferred from another hospital, reports a large observational study presented today at Acute Cardiovascular Care 2019, a European Society of Cardiology congress.
Among heart attack survivors, drug reduces chances of second heart attack or stroke
In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.
More Heart Attack News and Heart Attack Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.